Literature DB >> 22576713

Membrane-bound mucins and mucin terminal glycans expression in idiopathic or Helicobacter pylori, NSAID associated peptic ulcers.

Yaron Niv1, Doron Boltin, Marisa Halpern, Miriam Cohen, Zohar Levi, Alex Vilkin, Sara Morgenstern, Vahig Manugian, Erica St Lawrence, Pascal Gagneux, Surinder K Batra, Samuel B Ho.   

Abstract

BACKGROUND: The ratio of Helicobacter pylori/NSAID-negative gastric ulcers is increasing. Idiopathic gastric ulcers have unique clinical and endoscopic features, and are associated with more bleeding complications and a higher mortality. Alterations in gastric mucin expression and sialylation pattern may be important in ulcer pathogenesis. AIMS: The purpose of this study was to determine the expression pattern of membrane-bound mucins and side chain sugars in H. pylori associated-, NSAID-, and idiopathic-gastric ulcers.
METHODS: We randomly selected 92 patients with H. pylori (group 1, n = 30), NSAID (group 2, n = 18), combined H. pylori and NSAID associated gastric ulcers (group 3, n = 24), and patients with idiopathic gastric ulcers (group 4, n = 20). Immunohistochemistry for T-cell CD4/CD8, MUC1, MUC4, MUC17, and ECA and SNA lectins staining was performed on sections from the ulcer margins. Inflammation score was assessed according to the Sydney system.
RESULTS: Bleeding and mortality rates were significantly higher in group 4. CD4 positive T cell count was higher in H. pylori positive patients (P = 0.009). Staining intensity of MUC17 was higher in group 1 than in group 4, foveola and glands alike, with 11.50 ± 3.47 versus 6.80 ± 4.02, and 9.61 ± 4.26 versus 7.59 ± 3.26, respectively (P < 0.0001). This was a mirror image with MUC1. SNA lectin staining was increased in group 4, in parallel to MUC1 expression, indicating more abundant α2-6 sialylation in that group.
CONCLUSIONS: Cytoplasmic MUC17 staining was significantly decreased in the cases with idiopathic ulcer. The opposite was demonstrated for MUC1. This observation might be important, since different mucins with altered sialylation patterns likely differ in their protection efficiency against acid and pepsin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22576713     DOI: 10.1007/s10620-012-2205-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  MUC gene expression and histogenesis of adenocarcinoma of the stomach.

Authors:  S Tsukashita; R Kushima; M Bamba; H Sugihara; T Hattori
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

Review 2.  MUC1 and colorectal cancer pathophysiology considerations.

Authors:  Yaron Niv
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

3.  Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis.

Authors:  Ying Luu; Wade Junker; Satyanarayana Rachagani; Srustidhar Das; Surinder K Batra; Robert L Heinrikson; Laurie L Shekels; Samuel B Ho
Journal:  Int J Biochem Cell Biol       Date:  2010-03-06       Impact factor: 5.085

Review 4.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

Authors:  M F Dixon; R M Genta; J H Yardley; P Correa
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

5.  Helicobacter pylori moves through mucus by reducing mucin viscoelasticity.

Authors:  Jonathan P Celli; Bradley S Turner; Nezam H Afdhal; Sarah Keates; Ionita Ghiran; Ciaran P Kelly; Randy H Ewoldt; Gareth H McKinley; Peter So; Shyamsunder Erramilli; Rama Bansil
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-11       Impact factor: 11.205

Review 6.  Review article: Helicobacter pylori-negative duodenal ulcer disease.

Authors:  J P Gisbert; X Calvet
Journal:  Aliment Pharmacol Ther       Date:  2008-07-23       Impact factor: 8.171

Review 7.  How I manage H. pylori-negative, NSAID/aspirin-negative peptic ulcers.

Authors:  Kenneth E L McColl
Journal:  Am J Gastroenterol       Date:  2009-01       Impact factor: 10.864

8.  H. pylori decreases gastric mucin synthesis via inhibition of galactosyltransferase.

Authors:  Shouichi Tanaka; Motowo Mizuno; Toshirou Maga; Fumiya Yoshinaga; Jun Tomoda; Junichirou Nasu; Hiroyuki Okada; Kenji Yokota; Keiji Oguma; Yasushi Shiratori; Takao Tsuji
Journal:  Hepatogastroenterology       Date:  2003 Sep-Oct

9.  A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration.

Authors:  K E McColl; A M el-Nujumi; R S Chittajallu; S W Dahill; C A Dorrian; E el-Omar; I Penman; E J Fitzsimons; J Drain; H Graham
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

Review 10.  Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection.

Authors:  Motohiro Kobayashi; Heeseob Lee; Jun Nakayama; Minoru Fukuda
Journal:  Glycobiology       Date:  2009-01-15       Impact factor: 4.313

View more
  2 in total

1.  Mucins in Gastric Cancer - An Update.

Authors:  Doron Boltin; Yaron Niv
Journal:  J Gastrointest Dig Syst       Date:  2013-07-03

Review 2.  Gastroduodenal mucosal defense.

Authors:  Thomas Kemmerly; Jonathan D Kaunitz
Journal:  Curr Opin Gastroenterol       Date:  2013-11       Impact factor: 3.287

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.